» Articles » PMID: 35344607

A Propensity Score-matching Analysis of Angiotensin-converting Enzyme Inhibitor and Angiotensin Receptor Blocker Exposure on In-hospital Mortality in Patients with Acute Respiratory Failure

Overview
Journal Pharmacotherapy
Specialty Pharmacology
Date 2022 Mar 28
PMID 35344607
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objective: To explore the impact of pre-hospital ACEI and ARB exposure on the prognosis of ARF patients.

Design: A single-center retrospective cohort study.

Setting: Medical Information Mart for Intensive Care-III (MIMIC-III) database.

Patients: The patients meeting ICD-9 code of acute respiratory failure were enrolled.

Intervention: The primary exposure was the pre-hospital exposure of ACEI and ARB.

Measurement And Main Results: The primary outcome was in-hospital mortality. Multiple logistic regression analysis was conducted to determine the independent effect of ACEI/ARB exposure on mortality. Propensity score matching (PSM) method was adopted to reduce bias of the confounders. Subgroup analysis and sensitivity analysis were used to test the stability of the conclusion. 5335 adult ARF patients were enrolled. Mortality was significantly decreased in patients with ACEI/ARB exposure before and after PSM, and the adjusted odds ratio (OR) of ACEI/ARB exposure was 0.56 (95% CI 0.43-0.72). In the subgroup analysis, ACEI/ARB lost its protective effect in young subgroup, but no significant interaction was found between ACEI/ARB exposure and age (p = 0.082). The point estimation and lower 95% limit of E-value was 2.97 and 2.12. In sensitivity analysis, ACEI/ARB exposure showed similar effect in ARDS cohort, but no significantly difference was found in the MIMIC-IV database, which may be explained by small sample size of the ACEI/ARB group.

Conclusions: Among patients with acute respiratory failure, pre-hospital ACEI/ARB exposure was associated with better outcomes and acted as an independent factor. The relationship between ACEI/ARB and prognosis of ARF is worth investigating further.

Citing Articles

The association between the use of angiotensin-converting enzyme inhibitors /angiotensin receptor blockers and the development of ventilator-associated pneumonia in the intensive care unit: a retrospective cohort study.

Cai H, Shen H, Cao X BMC Pulm Med. 2024; 24(1):578.

PMID: 39574055 PMC: 11580205. DOI: 10.1186/s12890-024-03386-y.


Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients.

Fang Y, Huang X, Shi J, Ren C, Zhang X Front Pharmacol. 2024; 15:1385397.

PMID: 39268465 PMC: 11391424. DOI: 10.3389/fphar.2024.1385397.


Association of red cell distribution width and its changes with the 30-day mortality in patients with acute respiratory failure: An analysis of MIMIC-IV database.

Shi Y, Shi L, Chen F, Jiang Z, Sheng K PLoS One. 2023; 18(11):e0293986.

PMID: 37922307 PMC: 10624277. DOI: 10.1371/journal.pone.0293986.


The impact of aspirin exposure prior to intensive care unit admission on the outcomes for patients with sepsis-associated acute respiratory failure.

Lu Z, Fang P, Xia D, Li M, Li S, Wang Y Front Pharmacol. 2023; 14:1125611.

PMID: 36937880 PMC: 10014538. DOI: 10.3389/fphar.2023.1125611.


A propensity score-matching analysis of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker exposure on in-hospital mortality in patients with acute respiratory failure.

Fang Y, Zhang X Pharmacotherapy. 2022; 42(5):387-396.

PMID: 35344607 PMC: 9322533. DOI: 10.1002/phar.2677.

References
1.
Nicin L, Abplanalp W, Mellentin H, Kattih B, Tombor L, John D . Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts. Eur Heart J. 2020; 41(19):1804-1806. PMC: 7184464. DOI: 10.1093/eurheartj/ehaa311. View

2.
Kor D, Erlich J, Gong M, Malinchoc M, Carter R, Gajic O . Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients. Crit Care Med. 2011; 39(11):2393-400. PMC: 3196806. DOI: 10.1097/CCM.0b013e318225757f. View

3.
Huang B, Liang D, Zou R, Yu X, Dan G, Huang H . Mortality prediction for patients with acute respiratory distress syndrome based on machine learning: a population-based study. Ann Transl Med. 2021; 9(9):794. PMC: 8246239. DOI: 10.21037/atm-20-6624. View

4.
Textor J, Hardt J, Knuppel S . DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology. 2011; 22(5):745. DOI: 10.1097/EDE.0b013e318225c2be. View

5.
Matkovic Z, Huerta A, Soler N, Domingo R, Gabarrus A, Torres A . Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration. 2012; 84(1):17-26. DOI: 10.1159/000335467. View